
James Nadel
@docnadel
ID: 913151364229763072
27-09-2017 21:20:25
588 Tweet
637 Followers
317 Following


Differentiating VT Form SVT on #ECG can be challenging! We developed a user friendly algorithm based on clinical info and 2 leads (II,aVR). In a clinical validation residents and fellows are as proficient as #EPeeps JACC Journals tinyurl.com/44bfs5kx



ISCHEMIA-EXTENDED: Extended follow-up of the ISCHEMIA trial over a median 5.7 years showed initial invasive strategy vs initial conservative strategy resulted in no difference in all-cause mortality with nearly twice the number of deaths #AHA22 American College of Cardiology JACC Journals




Chen & colleagues found the in the absence of #bilirubin a hyperlipidemic pro-atherogenic phenotype. Learn more about how mild #jaundice protects against #HeartDisease at ahajrnls.org/411ZyEg CHEN Weiyu Sergey Tumanov James Nadel


Ever wondered how to perform ex vivo CCTA!? We show you how to here👇🏽 authors.elsevier.com/c/1gtbC6tu1i7b… …this technique can be used perform CT-based plaque characterization in the absence of prior in vivo #YesCCT Heart_SCCT Heart Research Institute UNSW Medicine & Health Heart Foundation #CardioTwitter

🗣️ just accepted in JACC Journals MPO activity is a hallmark of unstable human plaques & a potential diagnostic/therapeutic target! Read more 👉🏽 jacc.org/doi/10.1016/j.… Thanks to my co-authors & sponsors! Heart Research Institute Heart Foundation UNSW Medicine & Health NHMRC @SVHSydney

Made it to #EACVI2023. Wonder if anyone has travelled further 🦘🇦🇺 European Society of Cardiology? Come cheer me on at Teatro Científico tomorrow at 2pm where I’ll be presenting in the Young Investigator Award! 🫀 Heart Foundation NHMRC Heart Research Institute UNSW Medicine & Health @SVHSydney


That’s was fun! Thanks for having me #EACVI2023 🫀🇪🇸 Heart Research Institute UNSW Medicine & Health Heart Foundation NHMRC @SVHSydney


I won the Young Investigator Award at #EACVI2023 ! It’s amazing what’s classified as young these days. 🍾🫀🇪🇸 EACVI President Heart Research Institute Heart Foundation UNSW Medicine & Health NHMRC @SVHSydney




Excited to be speaking at CMR 2024 on molecular imaging of MPO activity & it’s application in vulnerable plaque. If you’re in the building come visit! #CMR2024 #cardiotwitter #whyCMR KCL Cardiac MRI Heart Research Institute @SVHSydney UNSW Medicine & Health Society for Cardiovascular Magnetic Resonance


#CardioTwitter our paper on MPO activity for imaging vulnerable plaque has just been published in European Society of Cardiology Journals!🫀 Read it here👇🏽 academic.oup.com/ehjimp/advance… Heart Research Institute KCL Cardiac MRI Heart Foundation UNSW Medicine & Health @SVHSydney NHMRC

As always, size isn't everything. Our study highlights the struggle of finding the 🪡 in the haystack of who will dissect + need for ⬆️ personalization of risk assessment. David Playford James Nadel CSANZ Heart Foundation academic.oup.com/ehjcimaging/ad…

The need for a paradigm shift in aortopathies by #WhyCMR 🧲 Great review just published on Journal of CMR Link: pubmed.ncbi.nlm.nih.gov/39986653 José F. Rodríguez Palomares Julián Vega Adauy Dr. Purvi Parwani Society for Cardiovascular Magnetic Resonance Ritu Thamman MD


Our latest paper on the future of MRI for assessing aortopathy is in Journal of CMR. Link 👉🏼 pubmed.ncbi.nlm.nih.gov/39986653/ We can do much more than current standard-of-care with #WhyCMR to improve risk predictions & outcomes for our patients.🫀 King's College London The Royal Australasian College of Physicians Heart Research Institute


❤️ 🧲 New review in @JCMR highlights how CMR 3D morphology, biomechanics, and molecular imaging can revolutionize thoracic aortopathy risk stratification. James Nadel explains below 👇 Free pdf 👉 journalofcmr.com/article/S1097-… #WhyCMR